Stanford researchers are spreading the virus to cancer patients hoping it may prove useful in fighting the deadly disease. Specifically, doctors injected end stage Colon Cancer patients with a modified cold virus. The theory was that the cold therapy would travel through the body targeting tumors without harming normal cells. In some patients, researchers say the therapy extended survival for a year and many saw their tumors shrink.
Of course, these are early study results, but researchers say they do suggest that along with causing a runny nose, the common cold may have some cancer fighting potential.